Safety Clinical Trials
0 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
SafetyLocally Advanced Non-Small Cell Lung CancerThoracic Radiotherapy
JIANYANG WANG44 enrolled1 locationNCT07037680
Recruiting
Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
Advanced Breast CancerESR1 Gene MutationSafety
SciClone Pharmaceuticals350 enrolled1 locationNCT06544577
Recruiting
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Breast CancerEfficacyLiposomal Doxorubicin+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University150 enrolled1 locationNCT05731258